Med Contacts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio GlobeNewswire January 10, 2022 MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed Contacts:Media: Will Harris, VP Marketing, MeMedpr@me-med.com IR: Kfir Emmer, CFO, MeMedkfir.emmer@me-med.comMedia Contacts:Consilium Strategic CommunicationsMeMed@consilium-comms.com

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV test recently cleared for use by US FDA to aid in distinguishing between bacterial and

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

MeMed Key® Wins Red Dot Award for High Design Quality April 22, 2021 07:00 ET | Source: MeMed MeMed , 2021 -frog, a leading global design and strategy consultancy, part of Capgemini Invent, and MeMed, a pioneer in the field of host immune response technology are proud to announce that MeMed Key ® has received the Red Dot Award for Product Design 2021. MeMed Key ® is a cutting-edge technology platform that allows highly sensitive and rapid measurements of multiple proteins at the point of need, empowering physicians to better diagnose and manage their patients in mu...